Table 3.
Non prior treatment | Prior treatment (TACE or HAIC) | ||
---|---|---|---|
Number | 58 | 13 | |
Age | 63.9 ± 10.3 | 62.6 ± 9.9 | p = 0.7322 |
Sex (male/female) | 14/4 | 15/8 | p = 0.2369 |
Etiology (HBV/HCV/NBNC) | 18/23/17 | 3/7/3 | p = 0.6470 |
Tumor size (mm) | 52.7 ± 40.8 | 28.6 ± 18.9 | p = 0.0118 |
ALT (IU/L) | 52.5 ± 42.7 | 35.8 ± 17.9 | p = 0.3683 |
γGTP (IU/L) | 95.6 ± 104.7 | 58.5 ± 29.4 | p = 0.4438 |
Plt (×103/μL) | 176.3 ± 61.6 | 172.8 ± 112.2 | p = 0.2553 |
Child-Pugh classification (A/B) | 58/0 | 11/2 | p = 0.024 |
AFP (ng/mL) | 1684.1 ± 6325.6 | 2529.1 ± 7414.3 | p = 0.6936 |
Data expressed as mean ± SD. Sex, etiology, and Child-Pugh were classification analyzed by χ 2 test. Other data were analyzed by Kruskal-Wallis test.